GlassScriptPhysician profile
Terri Lenigar
NPI 1013310259
$2,249.89
in general payments reported to CMS, 2019-2025
22 companies · $776 in 2025
The $776 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $121 · 2023: $526 · 2024: $620 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $485.99 | 2021-2025 | Nuzyra |
| Organogenesis INC. | $379.83 | 2023-2025 | Puraply, Puraply Wound Matrix, Apligraf |
| Kerecis Limited | $355.35 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Convatec INC. | $256.39 | 2021-2025 | |
| Reapplix INC. | $119.56 | 2025 | 3c Patch Kit - Box |
| Abbvie INC. | $112.05 | 2021-2025 | |
| Smith+Nephew, INC. | $106.37 | 2021-2025 | Collagenase Santyl, Grafix Pl |
| Integra Lifesciences Corporation | $76.20 | 2023-2025 | Integra, Tcc-Ez, Integra Dermal Regeneration Template |
| Kci USA, INC. | $70.69 | 2021-2023 | Activ.A.C. |
| Cumberland Pharmaceuticals, INC. | $47.88 | 2025 | Vibativ |
| Cashflow Solutions, LLC | $37.58 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Bioventus LLC | $34.95 | 2022 | |
| Tactile Systems Technology INC | $29.67 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Amgen INC. | $21.97 | 2025 | Krystexxa |
| Nestle Healthcare Nutrition INC. | $19.00 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $16.78 | 2024 | Activ.A.C. |
| Sunovion Pharmaceuticals INC. | $15.84 | 2021 | |
| Urgo Medical North America, LLC | $15.74 | 2025 | Urgoclean Ag |
| Hollister Incorporated | $15.66 | 2025 | |
| Lilly USA, LLC | $12.38 | 2021 | |
| Reprise Biomedical, INC. | $11.06 | 2024 | Miro3d |
| Biowound Solutions, INC. | $8.95 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terri Lenigar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.